[HTML][HTML] Complement activation in association with clinical outcomes in ST-elevation myocardial infarction
KE Kluge, MS Langseth, GØ Andersen… - … Journal Plus: Cardiology …, 2022 - Elsevier
… Consisting of soluble and cell-bound proteins, it can be … with emerging relevance in
cardiovascular disease is neutrophil … , Oslo, Norway for percutaneous coronary intervention (PCI) …
cardiovascular disease is neutrophil … , Oslo, Norway for percutaneous coronary intervention (PCI) …
[HTML][HTML] Impact of antiplatelet therapy on microvascular thrombosis during ST-elevation myocardial infarction
S Khattak, JN Townend, MR Thomas - Frontiers in Molecular …, 2024 - frontiersin.org
… Although emergency percutaneous coronary intervention (… mortality in patients with STEMI
but these patients were … major adverse cardiovascular events for patients with ST elevation MI …
but these patients were … major adverse cardiovascular events for patients with ST elevation MI …
JCS 2018 guideline on diagnosis and treatment of acute coronary syndrome
K Kimura, T Kimura, M Ishihara, Y Nakagawa… - Circulation …, 2019 - jstage.jst.go.jp
… of patients with ST-elevation acute myocardial infarction, the … , percutaneous coronary
intervention (PCI) with coronary stent … cardiovascular disease with a risk of cardiac events soon …
intervention (PCI) with coronary stent … cardiovascular disease with a risk of cardiac events soon …
[HTML][HTML] The year in cardiovascular medicine 2021: acute cardiovascular care and ischaemic heart disease
S Price, J Katz, CC Kaufmann, K Huber - European Heart Journal, 2022 - ncbi.nlm.nih.gov
… MI, myocardial infarction; CAD, coronary artery disease. … sites and higher levels of soluble
cytotoxic effector mediators. Finally, … in part to fewer percutaneous coronary intervention (PCI) …
cytotoxic effector mediators. Finally, … in part to fewer percutaneous coronary intervention (PCI) …
[HTML][HTML] Glycaemic Control in Patients Undergoing Percutaneous Coronary Intervention: What Is the Role for the Novel Antidiabetic Agents? A Comprehensive Review …
A Nusca, F Piccirillo, F Bernardini, A De Filippis… - International Journal of …, 2022 - mdpi.com
… managing patients with diabetes and cardiovascular diseases. … inhibits the assembly
of the membrane attack complex (MAC). … et al., patients without DM who suffered from ST-elevation …
of the membrane attack complex (MAC). … et al., patients without DM who suffered from ST-elevation …
[HTML][HTML] From classic to modern prognostic biomarkers in patients with acute myocardial infarction
… Myocardial infarction can be classified as ST-elevation … percutaneous coronary intervention.
The authors observed that … of negative cardiovascular events, such as cardiovascular death, …
The authors observed that … of negative cardiovascular events, such as cardiovascular death, …
CXC ligand 16 is an independent predictor of cardiovascular death and morbidity in acute coronary syndromes
T Andersen, T Ueland, T Ghukasyan Lakic… - … , and Vascular …, 2019 - Am Heart Assoc
… Ischemic heart disease remains the leading cause of death world-… in ST-elevation ACS
patients, which found steadily decreasing values after primary percutaneous coronary intervention…
patients, which found steadily decreasing values after primary percutaneous coronary intervention…
[HTML][HTML] Coronary No-Reflow after Primary Percutaneous Coronary Intervention—Current Knowledge on Pathophysiology, Diagnosis, Clinical Impact and Therapy
G Ndrepepa, A Kastrati - Journal of Clinical Medicine, 2023 - mdpi.com
… reflow are difficult to track because vascular events developing in … and microcirculation levels
by soluble vasoconstrictor substances … primary PCI in patients with ST-elevation Myocardial …
by soluble vasoconstrictor substances … primary PCI in patients with ST-elevation Myocardial …
Acute ST-elevation Myocardial Infarction and Interleukin-6 Inhibition Cardioprotection and Novel Therapeutic Strategies
AK Anstensrud - 2023 - duo.uio.no
… Today, percutaneous coronary intervention (PCI) is the … heart disease remains the most
common cause of death, and in … IL-6 binds to soluble IL-6R and the sIL6/IL6 complex can activate …
common cause of death, and in … IL-6 binds to soluble IL-6R and the sIL6/IL6 complex can activate …
[HTML][HTML] Complement component 7 is associated with total-and cardiac death in chest-pain patients with suspected acute coronary syndrome
R Aarsetøy, T Ueland, P Aukrust, AE Michelsen… - BMC Cardiovascular …, 2021 - Springer
… , myocardial infarction, coronary artery bypass grafting or percutaneous coronary intervention),
… high admission levels of soluble C5b-9 predicted future cardiovascular events, driven by …
… high admission levels of soluble C5b-9 predicted future cardiovascular events, driven by …